{"id":"W2158973015","doi":"10.1086/587993","title":"Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade B<i>gag/pol/nef</i>Vaccine in Healthy Adults","year":2008,"lang":"en","type":"article","venue":"Clinical Infectious Diseases","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":247,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Institute on Drug Abuse; Center for AIDS Research, University of Washington; International AIDS Vaccine Initiative; National Institutes of Health; School of Medicine, New York University; York University","keywords":"Immunogenicity; Medicine; Virology; Adverse effect; ELISPOT; HIV vaccine; Neutralizing antibody; Placebo; Virus; Immunology; Regimen; Antibody; Vaccination; Immune system; Vaccine trial; Internal medicine; T cell","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003642624,0.0001818575,0.0004008739,0.00008078696,0.0001353311,0.000007656523,0.0002074014,0.0001894126,0.0000488035],"category_scores_gemma":[0.001002757,0.0001758248,0.0001688406,0.0002629576,0.000264486,0.000006870599,0.0001854956,0.0002334472,0.00001878966],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003933488,"about_ca_system_score_gemma":0.000352484,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001199956,"about_ca_topic_score_gemma":0.0004457098,"domain_scores_codex":[0.9977052,0.0003477649,0.0008263183,0.0006431077,0.000174715,0.0003028626],"domain_scores_gemma":[0.9983041,0.0001610517,0.0002175183,0.0008769428,0.0001854561,0.0002549318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04255377,0.001854502,0.9233247,0.00009044488,0.0001801349,0.00001675432,0.00004450605,0.0001239461,0.02111384,0.00002533782,0.0007271941,0.009944868],"study_design_scores_gemma":[0.008183337,0.01383371,0.9638619,0.0000567945,0.00004177449,0.00003410473,0.0000213185,0.0001594344,0.008707691,0.0001047173,0.00464563,0.0003495506],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924912,0.006410041,0.00003279246,0.0002968905,0.0001066163,0.0004201103,0.00009055367,0.00002835557,0.0001233656],"genre_scores_gemma":[0.9835867,0.01525625,0.00001892082,0.0006624103,0.0001981859,0.000028203,0.0001569832,0.00002763768,0.00006466745],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04053725,"threshold_uncertainty_score":0.7169929,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02940967443426321,"score_gpt":0.3595694906119105,"score_spread":0.3301598161776473,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}